65,437 trials
Stage IIB Breast Cancer · Stage IIIA Breast Cancer · Stage IIIB Breast Cancer
Primary: %Change in FLT Uptake Between the Baseline (Pre-therapy) and the Early-therapy Imaging Studies to Predict Pathological Complete Response — 38.78 percentage change of…
Healthy
Primary: Physical Function (CS-PFP Total Score) — 3.1; 3.6; 0.8; 3.3 units on a scale — p=<0.025
Presbyopia
Primary: Driving Reaction Time to Hazards (as Measured by Time to Brake, in Seconds) — 1.89; 1.88 seconds
Adult Malignant Fibrous Histiocytoma of Bone · Desmoid Tumor · Endometrial Cancer
Primary: Overall Objective Response — 1; 21; 26 participants
Brain and Central Nervous System Tumors · Prostate Cancer
Primary: Overall Objective Response — 0; 0; 2; 0 participants
Wound Infection
Primary: The Percentage of Patients Who Had a 50% or Greater Wound Size Volume Reduction After 4 Weeks of Treatment With the Next Science Wound Gel, as Compared to Wounds Treated…
Pneumonia
Primary: Maximum Observed Plasma Concentration (Cmax) of CP-70429 Following CP-70,429 Intravenous Dose — 17700; 22070; 28940; 10340 nanogram per milliliter (ng/mL)
Glaucoma · Application Site Pigmentation Changes
Primary: The Extent of Latanoprost, Bimatoprost and Travoprost Induced Periocular Skin Hyperpigmentation Over a One Year Time Course in Newly Diagnosed Primary Open Angle and…
Conjunctivitis
Primary: Number of Participants With Normal Physical Examination of the Eye — 49; 37 participants
Renal Failure
Primary: Evaluation of T(Max) for Envarsus XR, Astagraf XL and Prograf. — 5.91; 1.93; 1.48 hour
Gaucher Disease
Primary: Hemoglobin — 10.6; 11.2; 13.5; 11.9 g/dL
Alcohol Dependence · Stress Disorders, Post-Traumatic
Primary: Number of Drinking Days — 11.04; 9.21 days
Presbyopia · Refractive Error
Primary: Area for Each Region (Near and Intermediate) Under the Mean Defocus Curve (AUC) at High Luminance — 0.09; 0.18; 0.24; 0.36 diopter*logMar
Cardiovascular Diseases
Primary: Technical Success Rate — 98.1 percentage of participants
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Trough Morning Forced Expiratory Volume in 1 Second (FEV1) at Day 85 — 0.116; 0.091 Liters (L)